Cite
Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
MLA
Conway, Devon S., et al. “Measures of Thalamic Integrity Are Associated with Cognitive Functioning in Fingolimod-Treated Multiple Sclerosis Patients.” Multiple Sclerosis and Related Disorders, vol. 47, Jan. 2021, p. 102635. EBSCOhost, https://doi.org/10.1016/j.msard.2020.102635.
APA
Conway, D. S., Planchon, S. M., Oh, S. H., Nakamura, K., Thompson, N. R., Sakaie, K., & Ontaneda, D. (2021). Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients. Multiple Sclerosis and Related Disorders, 47, 102635. https://doi.org/10.1016/j.msard.2020.102635
Chicago
Conway, Devon S, Sarah M Planchon, Se Hong Oh, Kunio Nakamura, Nicolas R Thompson, Ken Sakaie, and Daniel Ontaneda. 2021. “Measures of Thalamic Integrity Are Associated with Cognitive Functioning in Fingolimod-Treated Multiple Sclerosis Patients.” Multiple Sclerosis and Related Disorders 47 (January): 102635. doi:10.1016/j.msard.2020.102635.